Previous Article | Next Article ![]()
Journal of Clinical Microbiology, February 2000, p. 558-562, Vol. 38, No. 2
Service de Dermatologie (DHURDV), Centre
Hospitalier Universitaire Vaudois, Lausanne,
Switzerland,1 and Dunhill Dermatology
Laboratory, St Johns Institute of Dermatology, Guy's, King's and St
Thomas' Medical Schools, Guy's Hospital, London, United
Kingdom2
Received 15 June 1999/Returned for modification 11 September
1999/Accepted 2 November 1999
The Cu,Zn superoxide dismutase (SOD) of Aspergillus
fumigatus has previously been purified and shown to be
immunoreactive to the sera of patients with aspergillosis; however, the
purification of large quantities of the enzyme for expanded
immunological analysis is both difficult and time-consuming.
Accordingly, a
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Production and Characterization of Recombinant
Aspergillus fumigatus Cu,Zn Superoxide Dismutase and Its
Recognition by Immune Human Sera
EMBL3 A. fumigatus genomic library was
screened with degenerate oligonucleotides based on N-terminal amino
acid sequence data; from this initial screen a 1,400-bp fragment was
identified, labelled, and used to screen an A. fumigatus
gt11 cDNA library. A full-length cDNA encoding Cu,Zn SOD was
subsequently identified and cloned. The cDNA encodes a protein of 154 amino acids, which does not have a signal peptide. The A. fumigatus Cu,Zn SOD possesses the typical metal binding ligands
of fungal Cu,Zn SODs (six histidines and one aspartic acid) and has
significant overall homology with Cu,Zn SODs in general. A recombinant
A. fumigatus Cu,Zn SOD has been expressed in Pichia
pastoris, is enzymatically active, and has biochemical and
biophysical properties that are similar to those of the native enzyme.
A sheep polyclonal antibody raised against purified native A. fumigatus Cu,Zn SOD was reactive to the recombinant enzyme by
immunoenzyme development of Western blots. Sixty percent of serum
samples from patients with A. fumigatus infections were reactive against the recombinant Cu,Zn SOD via immunoenzyme development of Western blots, indicating that the recombinant protein may be useful
in the serodiagnostic identification of A. fumigatus infections.
*
Corresponding author. Mailing address: Dunhill
Dermatology Laboratory, 5th Floor, Thomas Guy House, Guys Hospital,
London SE1 9RT, United Kingdom. Phone: 0171 955 4663. Fax: 0171 407 6689. E-mail: m.holdom{at}umds.ac.uk.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|